NCT03993353 2026-02-12Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerUniversity of California, San DiegoPhase 2 Completed7 enrolled 14 charts
NCT04069936 2022-08-02Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILsâ„¢ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLCWindMIL TherapeuticsPhase 2 Terminated19 enrolled